Results 271 to 280 of about 9,915,167 (360)
The Impact of Radioiodine (131I) Therapy of Thyroid Disease on Salivary Glands Function and Inflammation: A Comprehensive Review. [PDF]
Bellini P +11 more
europepmc +1 more source
Aims Major adverse cardiovascular events (MACE) related to cardiovascular disease are a major cause of death in patients with metabolic dysfunction‐associated steatotic liver disease (MASLD). We explored the impact of MASLD on incident MACE and overall mortality in the general population in Germany.
Yvonne Huber +15 more
wiley +1 more source
Management of benign nodular thyroid disease: a nationwide survey of endocrine specialists in Spain. [PDF]
Díez JJ, Galofré JC.
europepmc +1 more source
Global patterns of polypharmacy after acute heart failure hospitalization. GDMT, guideline‐directed medical therapy; HF, heart failure. Aims Polypharmacy, defined as the concurrent use of ≥5 medications, is prevalent among older adults with heart failure (HF).
Wan Ting Tay +19 more
wiley +1 more source
Abstract Objective Autoimmune mechanisms are a recognized cause of adult epilepsy, with immunotherapy offering etiology‐specific treatment. Autoimmune‐associated epilepsy is an emerging clinical entity, for which early diagnosis remains challenging and largely depends on neuronal antibody testing.
I‐Ting Lin +5 more
wiley +1 more source
Indications, sub-types and complications of surgically treated thyroid disease in Africa: A systematic review and meta-analysis. [PDF]
Getachew B, Afework M, Tamrat G.
europepmc +1 more source
Cross‐species extrapolation of adverse outcome pathway network on reproductive toxicity under the One Health perspective using new approach methodologies. AOP = adverse outcome pathway. Abstract Although ecotoxicological and toxicological risk assessments are performed separately from each other, recent efforts have been made in both disciplines to ...
Elizabeth Dufourcq Sekatcheff +2 more
wiley +1 more source
The impact of autoimmune thyroid disease on cognitive and psychiatric disorders: focus on clinical, pre-clinical and molecular studies. [PDF]
Piekiełko-Witkowska A +3 more
europepmc +1 more source
Correction: <sup>131</sup>I therapy for benign thyroid disease: flexible single-time-point dosimetry using population-based model selection with non-linear mixed-effects modelling. [PDF]
Hardiansyah D +6 more
europepmc +1 more source

